240 related articles for article (PubMed ID: 32173425)
21. Withania somnifera: From prevention to treatment of cancer.
Palliyaguru DL; Singh SV; Kensler TW
Mol Nutr Food Res; 2016 Jun; 60(6):1342-53. PubMed ID: 26718910
[TBL] [Abstract][Full Text] [Related]
22. Metabolomic and biotechnological approaches to determine therapeutic potential of Withania somnifera (L.) Dunal: A review.
Tripathi N; Shrivastava D; Ahmad Mir B; Kumar S; Govil S; Vahedi M; Bisen PS
Phytomedicine; 2018 Nov; 50():127-136. PubMed ID: 30466971
[TBL] [Abstract][Full Text] [Related]
23. Effects of Withania somnifera and Tinospora cordifolia extracts on the side population phenotype of human epithelial cancer cells: toward targeting multidrug resistance in cancer.
Maliyakkal N; Appadath Beeran A; Balaji SA; Udupa N; Ranganath Pai S; Rangarajan A
Integr Cancer Ther; 2015 Mar; 14(2):156-71. PubMed ID: 25549922
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological potential of
Rizvi ZA; Babele P; Madan U; Sadhu S; Tripathy MR; Goswami S; Mani S; Dikshit M; Awasthi A
Front Immunol; 2023; 14():1138215. PubMed ID: 36960064
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and bioequivalence of
Kim SK; Venkatesan J; Rathi P; Antony B
Heliyon; 2023 Dec; 9(12):e22843. PubMed ID: 38144272
[TBL] [Abstract][Full Text] [Related]
26. Withania somnifera extracts induced attenuation of HIV-1: a mechanistic approach to restrict viral infection.
Jadaun P; Harshithkumar R; Gaikwad SY; Seniya C; Borse S; Gawai AA; Chavan-Gautam P; Tillu G; Mukherjee A
Virol J; 2023 Aug; 20(1):173. PubMed ID: 37537596
[TBL] [Abstract][Full Text] [Related]
27. Evaluating the inhibitory potential of Withania somnifera on platelet aggregation and inflammation enzymes: An in vitro and in silico study.
M M; Zameer F; Naidu A; M N NP; Dhananjaya BL; Hegdekatte R
Pharm Biol; 2016 Sep; 54(9):1936-41. PubMed ID: 26704448
[TBL] [Abstract][Full Text] [Related]
28. Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAĻ receptors.
Candelario M; Cuellar E; Reyes-Ruiz JM; Darabedian N; Feimeng Z; Miledi R; Russo-Neustadt A; Limon A
J Ethnopharmacol; 2015 Aug; 171():264-72. PubMed ID: 26068424
[TBL] [Abstract][Full Text] [Related]
29. Withania somnifera - a magic plant targeting multiple pathways in cancer related inflammation.
Kumar P; Sharma R; Garg N
Phytomedicine; 2022 Jul; 101():154137. PubMed ID: 35533610
[TBL] [Abstract][Full Text] [Related]
30. Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression.
Saggam A; Kale P; Shengule S; Patil D; Gautam M; Tillu G; Joshi K; Gairola S; Patwardhan B
Front Pharmacol; 2022; 13():835616. PubMed ID: 35273508
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects.
Mandlik Ingawale DS; Namdeo AG
J Diet Suppl; 2021; 18(2):183-226. PubMed ID: 32242751
[No Abstract] [Full Text] [Related]
32. Withaferin A: From Ancient Remedy to Potential Drug Candidate.
Sultana T; Okla MK; Ahmed M; Akhtar N; Al-Hashimi A; Abdelgawad H; Haq IU
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946778
[TBL] [Abstract][Full Text] [Related]
33. Ashwagandha: Advances in plant biotechnological approaches for propagation and production of bioactive compounds.
Namdeo AG; Ingawale DK
J Ethnopharmacol; 2021 May; 271():113709. PubMed ID: 33346029
[TBL] [Abstract][Full Text] [Related]
34. Effect of Withania somnifera Dunal Root Extract on Behavioral Despair Model in Mice: a Possible Role for Nitric Oxide.
Attari M; Jamaloo F; Shadvar S; Fakhraei N; Dehpour AR
Acta Med Iran; 2016 Mar; 54(3):165-72. PubMed ID: 27107520
[TBL] [Abstract][Full Text] [Related]
35. Caffeine withdrawal retains anticataleptic activity but Withania somnifera withdrawal potentiates haloperidol-induced catalepsy in mice.
Kasture S; Barhate S; Mohan M; Ballero M; Sanna C; Maxia A
Nat Prod Res; 2009; 23(8):724-8. PubMed ID: 19418355
[TBL] [Abstract][Full Text] [Related]
36.
Singh M; Jayant K; Singh D; Bhutani S; Poddar NK; Chaudhary AA; Khan SU; Adnan M; Siddiqui AJ; Hassan MI; Khan FI; Lai D; Khan S
Front Cell Infect Microbiol; 2022; 12():933824. PubMed ID: 36046742
[TBL] [Abstract][Full Text] [Related]
37. Withanolides from Withania somnifera Dunal: development of cellular technology and their production.
Sangwan NS; Sabir F; Mishra S; Bansal S; Sangwan RS
Recent Pat Biotechnol; 2014; 8(1):25-35. PubMed ID: 24354530
[TBL] [Abstract][Full Text] [Related]
38. Neuropharmacological Properties of Withania somnifera - Indian Ginseng: An Overview on Experimental Evidence with Emphasis on Clinical Trials and Patents.
Yenisetti SC; Manjunath MJ; Muralidhara C
Recent Pat CNS Drug Discov; 2016; 10(2):204-215. PubMed ID: 27316579
[TBL] [Abstract][Full Text] [Related]
39. Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress.
Bhattacharya SK; Muruganandam AV
Pharmacol Biochem Behav; 2003 Jun; 75(3):547-55. PubMed ID: 12895672
[TBL] [Abstract][Full Text] [Related]
40. Withania somnifera Improves Ischemic Stroke Outcomes by Attenuating PARP1-AIF-Mediated Caspase-Independent Apoptosis.
Raghavan A; Shah ZA
Mol Neurobiol; 2015 Dec; 52(3):1093-1105. PubMed ID: 25294638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
